With 31.6% of Huge CAGR AI for Drug Discovery and Development Market to Hit USD 4.81 Billion by 2027

Pune, Maharashtra, India, September 10 2020 (Wiredrelease) Allied Analytics –:The Artificial Intelligence for Drug Discovery and Development Market generated $520.00 million in 2019, and is estimated to reach $4.81 billion by 2027, registering a CAGR of 31.6% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios.

Surge in cross industry collaborations and partnerships to boost the drug discovery drives the growth of the global artificial intelligence for drug discovery and development market. However, lack of skilled professional restrains the market growth. Furthermore, growing awareness related to artificial intelligence is expected to provide new opportunities for market players in near future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5239

Covid-19 scenario:

• Due to Covid-19 outbreak, artificial intelligence for drug discovery and development market have grown significantly. This is due to surge in adoption of AI with rise in number of partnership between AI providers and pharma and biotech companies to develop drug for treatment of patients affected from coronavirus.

• The demand for AI for drug discovery and development has been surged as it helps to understand the protein structure of the virus and plays an integral role in drug design and accelerating vaccine technologies.

The report offers a detailed segmentation of the global artificial intelligence for drug discovery and development market based on type, indication, end-user, and region.

Based on type, the preclinical and clinical testing segment contributed to the largest share in 2019, accounting for more than one-third of the total share, and is estimated to maintain its dominant position during the forecast period. However, the De Novo drug design and drug optimization segment is estimated to portray the highest CAGR during the forecast period.

Based on indication, the oncology segment is expected to register the fastest CAGR of 32.6% from 2020 to 2027.By end user, the pharmaceutical and biotechnology companies segment accounted for more than four-fifths of total share of the artificial intelligence for drug discovery and development market in 2019, and will maintain its dominance by 2027.

Based on region, North America contributed the highest share in 2019, accounting for more than half of the global market, and will maintain its dominant position throughout the forecast period. However, Asia-pacific is expected to grow at the highest CAGR from 2020 to 2027.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5239

Leading market players-

• Atomwise, Inc.
• Alphabet Inc.
• Cloud Pharmaceutical
• Benevolent AI
• Exscientia, Deep Genomics
• Insilico Medicine Inc.
• IBM Corporation
• Nvidia Corporation
• Microsoft Corporation

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

Ischemic Heart Disease Drugs Market – Global Opportunity Analysis and Industry Forecast, 2019–2026

Placental Protein Market – Global Opportunity Analysis and Industry Forecast, 2019–2026

Endometrial Ablation Market – Opportunity Analysis and Industry Forecast, 2019-2026

Pediatrics Medicine Market – Global Opportunity Analysis and Industry Forecast, 2019-2026

Surgical Power Tools Market – Global Opportunity Analysis and Industry Forecast, 2019-2026

About Us                                                                                                      

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. 

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.